4//SEC Filing
KHOSLA CHAITAN PHD 4
Accession 0001209191-20-046427
CIK 0001377121other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 5:38 PM ET
Size
9.2 KB
Accession
0001209191-20-046427
Insider Transaction Report
Form 4
KHOSLA CHAITAN PHD
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2020-08-11−2,499→ 7,499 totalExercise: $1.89Exp: 2024-10-22→ Common Stock (2,499 underlying) - Exercise/Conversion
Common Stock
2020-08-11$1.89/sh+2,499$4,723→ 2,499 total - Sale
Common Stock
2020-08-11$17.19/sh−2,499$42,952→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.91 to $17.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]This option is fully vested.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001135139
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 5:38 PM ET
- Size
- 9.2 KB